The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
Top Cited Papers
Open Access
- 18 February 2011
- journal article
- review article
- Published by Wiley in Molecular Oncology
- Vol. 5 (2), 164-182
- https://doi.org/10.1016/j.molonc.2011.02.001
Abstract
Cancer testis antigens (CTA) are a large family of tumor‐associated antigens expressed in human tumors of different histological origin, but not in normal tissues except for testis and placenta. This...Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG 6038, MFAG 9195)
- Fondazione Monte dei Paschi di Siena
- Harry J. Lloyd Charitable Trust
- Istituto Superiore di Sanità
- Istituto Toscano Tumori
This publication has 194 references indexed in Scilit:
- Epigenetically regulated clonal heritability of CTA expression profiles in human melanomaJournal of Cellular Physiology, 2010
- Quantitative expression and immunogenicity of MAGE‐3 and ‐6 in upper aerodigestive tract cancerInternational Journal of Cancer, 2009
- Cancer testis antigens in human melanoma stem cells: Expression, distribution, and methylation statusJournal of Cellular Physiology, 2008
- Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancerProceedings of the National Academy of Sciences of the United States of America, 2007
- Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applicationsJournal of Cellular Physiology, 2007
- Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-primingProceedings of the National Academy of Sciences of the United States of America, 2007
- Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patientsProceedings of the National Academy of Sciences of the United States of America, 2006
- MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agentsProceedings of the National Academy of Sciences of the United States of America, 2006
- Genomic DNA methylation: the mark and its mediatorsTrends in Biochemical Sciences, 2006
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003